Genentech Inc.

In News

Biocon settles Roche's US patent lawsuit over proposed breast-cancer drug copy - Reuters

Reuters - Oct 14, 2026

Genentech Wins Judge's OK Of $18M Novartis Award - Law360

Law360 - Oct 15, 2026

Genentech Drops Lawsuit Against Biocon Over Perjeta Biosimilar - Bloomberg Law News

Bloomberg Law News - Oct 14, 2026

Genentech pens $1.27B deal to access Alector’s preclinical blood-brain barrier asset - BioSpace

BioSpace - Oct 05, 2026

Alector Enters Global License Agreement with Genentech for - GlobeNewswire

GlobeNewswire - Oct 05, 2026

Roundup: Shionogi Inc. Acquires IntraBio, Gate Bioscience extends Collaboration with Eli Lilly, Alector Enters Global License Agreement with Genentech - Pharmaceutical Executive

Pharmaceutical Executive - Oct 06, 2026

Here's what you get when you mix AI, an ex-Genentech trio, a knotty healthcare system and a half-billion dollars - The Business Journals

The Business Journals - Sep 29, 2026

Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair - Fierce Pharma

Fierce Pharma - Jun 23, 2026

A Parkinson’s drug deal could mean up to $1.17 billion for Alector if future goals are met. - Stock Titan

Stock Titan - Oct 05, 2026

Biocon inks patent settlement pact with Genentech for breast cancer drug - Business Standard

Business Standard - Oct 14, 2026

Genentech Announces Manufacturing Expansion in Hillsboro, Oregon - Yahoo Finance

Yahoo Finance - Aug 20, 2026

Exclusive: Genentech parts ways with a key AI leader in latest high-profile exit - Endpoints News

Endpoints News - Oct 06, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment